Gold tier: mechanically validated evidence, with its primary source.
7 evidence items · page 1 / 1
4.3 %HCV prevalence was 4.3% among HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
3.7 %HCV prevalence was 3.7% among HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
3.9 %HCV prevalence was 3.9% among HIV-infected adult patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
70 %Detectable HCV RNA was identified in 70.0% of anti-HCV positive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
100 %Detectable HCV RNA was identified in 100% of anti-HCV positive HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
43.8 %Detectable HCV RNA was identified in 43.8% of anti-HCV positive HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
4 %HCV prevalence was 4.0% among HIV-1&2 dually reactive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.